Telisotuzumab Vedotin
82922
TargetMET
Product group Antibodies
Overview
- SupplierBPS Bioscience
- Product NameTelisotuzumab Vedotin
- Delivery Days Customer23
- CertificationResearch Use Only
- ClonalityMonoclonal
- Estimated Purity≥90%
- Gene ID4233
- Target nameMET
- Target descriptionMET proto-oncogene, receptor tyrosine kinase
- Target synonymsAUTS9, DA11, DFNB97, HGFR, RCCP2, c-Met, hepatocyte growth factor receptor, HGF receptor, HGF/SF receptor, SF receptor, proto-oncogene c-Met, scatter factor receptor, tyrosine-protein kinase Met
- Protein IDP08581
- Protein NameHepatocyte growth factor receptor
- Scientific DescriptionTelisotuzumab vedotin (ABBV-399) is an antibody-drug conjugate (ADCs) targeting c-Met. Telisotuzumab vedotin consists of Monomethyl Auristatin E (MMAE), Telisotuzumab antibody and a cleavable mc-val-cit-PABC type linker. Telisotuzumab vedotin can be used to study non-small cell lung cancer expressing c-Met protein1,2.
- Storage Instruction-80°C
- UNSPSC12352203





